Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2025-12-24 @ 3:37 PM
NCT ID:
NCT02448992
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of NSCLC
* Must be adult patients (≥ 18 years old) who have received definitive surgery and have a permanent pathology of nodal metastasis
* Platinum-based chemotherapy is mandatory
* Good performance status better than Eastern Cooperative Group (ECOG) of 2 or a general status of Karnofsky (KPS) \> 70 %
* Should have sufficient proficiency in Mandarin language
Exclusion Criteria:
* Have received prior cranial irradiation
* Presence of other active primary cancer (exception of basal cell carcinoma of skin and cervical carcinoma in situ)
* Radiographic evidence of brain metastasis/metastases
* Clinical evidence of extracranial metastatic disease
* Hypersensitivity to magnetic resonance (MR) contrast enhancer
* Serious medical or psychiatric illness
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02448992
Study Brief:
Protocol Section:
NCT02448992